One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
ACR Presidential Address: The American College of Rheumatology in 2025 – The Strength, Resilience, and Importance of Our Rheumatology Community
doi : 10.1002/art.70064
Where You Live Shouldn't Dictate Your Care: Multilateral Strategies Are Needed for National and Regional Equity in Psoriatic Arthritis Treatment
doi : 10.1002/art.70063
Optimizing Hydroxychloroquine in Lupus Treatment: Looking Beyond the 5-mg/kg Weight-Based Dosing Cutoff
doi : 10.1002/art.70062
National Mortality Databases to Assess Disease Burden in Systemic Autoimmune Diseases: A Valuable Resource But With Limitations
doi : 10.1002/art.43410
Are Glucocorticoids Associated With Worse Survival Among Patients With Rheumatoid Arthritis and Lung Cancer Treated With Immune Checkpoint Inhibitors?
doi : 10.1002/art.43445
Plasma Proteomics Identifies Thousand-and-One–Amino Acid Kinase 3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target
doi : 10.1002/art.70020
Tumor Necrosis Factor–Induced Neuropilin-2 in Fibroblast-Like Synoviocytes Exacerbates Rheumatoid Arthritis
doi : 10.1002/art.70028
Per- and Polyfluoroalkyl Substances and Hand Osteoarthritis: Data From the Osteoarthritis Initiative
doi : 10.1002/art.70026
Myeloid-Derived Suppressor Cell–Derived Interferon-β Promotes T Follicular Helper Cell Response and Exacerbates Lupus Development
doi : 10.1002/art.70004
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring
doi : 10.1002/art.70010
Weighing Dose-Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
doi : 10.1002/art.70022
Molecular Stratification of Antiphospholipid Syndrome Through Integrative Analysis of the Whole-Blood RNA Transcriptome
doi : 10.1002/art.70021
Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab
doi : 10.1002/art.70025
Antineutrophil Cytoplasmic Antibody–Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes
doi : 10.1002/art.70032
Single-Cell Profiling Reveals Divergent Mechanisms of Fibrosis in Localized Scleroderma and Systemic Sclerosis
doi : 10.1002/art.70039
Decision Tree Analysis as a Preliminary Evidence-Based Tool for Identifying the Syndrome of Undifferentiated Recurrent Fever in Children Compared With Hereditary Recurrent Fevers and Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome
doi : 10.1002/art.70019
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis
doi : 10.1002/art.70002
Nociplasticity, rather than fibromyalgia, best conceptualizes symptoms not linked to well-defined organ disease in systemic lupus erythematosus: comment on the article by Pisetsky et al
doi : 10.1002/art.43426
